Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Current Assets (2016 - 2018)

Armata Pharmaceuticals' Current Assets history spans 6 years, with the latest figure at $5.1 million for Q3 2018.

  • For Q3 2018, Current Assets fell 35.99% year-over-year to $5.1 million; the TTM value through Sep 2018 reached $5.1 million, down 35.99%, while the annual FY2017 figure was $5.4 million, 14.7% down from the prior year.
  • Current Assets for Q3 2018 was $5.1 million at Armata Pharmaceuticals, down from $6.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $17.0 million in Q1 2015 and bottomed at $2.6 million in Q1 2017.
  • The 5-year median for Current Assets is $7.9 million (2016), against an average of $9.0 million.
  • The largest annual shift saw Current Assets crashed 66.02% in 2014 before it skyrocketed 241.52% in 2018.
  • A 5-year view of Current Assets shows it stood at $7.0 million in 2014, then soared by 78.95% to $12.6 million in 2015, then crashed by 49.75% to $6.3 million in 2016, then dropped by 14.7% to $5.4 million in 2017, then dropped by 5.03% to $5.1 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Current Assets are $5.1 million (Q3 2018), $6.1 million (Q2 2018), and $8.7 million (Q1 2018).